You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Recruiting
  • Relapsed Hematologic Malignancy
  • Multiple Myeloma
  • Montréal, Quebec, Canada
    CIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maiso
2021-08-13
Aug 13, 2021
M
Completed
  • Relapsed Hematologic Malignancy
  • ngFDS selected treatment
  • Vienna, Austria
    Medical University Vienna
2021-02-22
Feb 22, 2021
C
Recruiting
  • Relapsed Hematologic Malignancy
  • Refractory Hematologic Malignancy
  • Phoenix, Arizona
  • +9 more
2021-04-30
Apr 30, 2021
J
Recruiting
  • Malignant Disease
  • +5 more
  • Fairway, Kansas
    University of Kansas Cancer Center - CRC
2021-04-29
Apr 29, 2021
M
Recruiting
  • Hematologic Malignancy
  • +5 more
  • CAR-37 T cells
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
2021-10-28
Oct 28, 2021
i
Recruiting
  • Hematologic Malignancy
  • +4 more
  • CLL1-CD33 cCAR T cells
  • Chengdu, China
  • +1 more
2021-05-17
May 17, 2021
H
Recruiting
  • Acute Lymphoblastic Leukemia
  • Non-hodgkin Lymphoma
  • Hangzhou, Zhejiang, China
    The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
2020-12-24
Dec 24, 2020
Z
Recruiting
  • CD7+ Acute Leukemia
  • CD7+ Lymphoma
  • anti-CD7 CAR-T
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital,College of Medicine, Zhejiang Univ
2021-10-26
Oct 26, 2021
F
Recruiting
  • Advanced Hematologic Malignancy
  • +4 more
  • Boston, Massachusetts
  • +4 more
2021-10-08
Oct 8, 2021
I
Not yet recruiting
  • Advanced or Metastatic Solid Tumor
  • Relapsed Hematologic Malignancy
  • IPPACTTO
  • Cholet, France
  • +5 more
2020-03-30
Mar 30, 2020
M
Terminated
  • Acute Leukemia
  • +3 more
  • Nivolumab (.25 mg/kg)
  • +2 more
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
2021-10-04
Oct 4, 2021
M
Active, not recruiting
  • Haematological Malignancy
  • Nivolumab Injection
  • Parkville, Victoria, Australia
    Royal Melbourne Hospital
2021-09-21
Sep 21, 2021
A
Recruiting
  • Relapsed Hematologic Malignancy
  • donor-derived CIK cells
  • Bergamo, Italy
    A O Papa Giovanni XXIII
2019-01-29
Jan 29, 2019
H
Recruiting
  • Acute Lymphoblastic Leukemia
  • Non-Hodgkin's Lymphoma
  • CT-RD06
  • Hangzhou, Zhejiang, China
    The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
2020-02-19
Feb 19, 2020
C
Recruiting
  • Solid Tumor
  • Hematologic Malignancy
  • Beijing, China
    Department of Biotherapeutic, Chinese PLA General Hospital
2021-10-18
Oct 18, 2021
H
Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Hematological Malignancy
  • Maroochydore, Queensland, Australia
  • +2 more
2020-12-21
Dec 21, 2020
i
Unknown status
  • Hematologic Malignancy
  • +4 more
  • CD123-CD33 cCAR T cells
  • Chengdu, China
  • +1 more
2019-11-08
Nov 8, 2019
U
Recruiting
  • Previously Treated Myelodysplastic Syndrome
  • +3 more
  • Fludarabine Phosphate
  • +9 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
2021-01-05
Jan 5, 2021
I
Completed
  • Hematological Malignancy
  • +3 more
  • AlloStim
  • Jerusalem, Israel
    Hadassah-Hebrew University Medical Center
2020-01-17
Jan 17, 2020
N
Completed
  • Allogeneic Hematopoietic Stem Cell Transplant Recipient
  • +10 more
  • Ipilimumab
  • +2 more
  • Duarte, California
  • +12 more
2021-06-23
Jun 23, 2021
C
Recruiting
  • Recurrent Acute Leukemia
  • +16 more
  • Duarte, California
    City of Hope Medical Center
2021-11-01
Nov 1, 2021
G
Terminated
  • Hematologic Malignancy
  • Acute Myeloid Leukemia
  • Fukui, Japan
  • +5 more
2020-02-21
Feb 21, 2020
S
Not yet recruiting
  • Hematologic Malignancies
  • Shanghai, Shanghai, China
    Ruijin Hospital of Shanghai Jiaotong University School of Medici
2021-11-02
Nov 2, 2021
I
Recruiting
  • Hematologic Malignancy
  • IBI322
  • Zhejiang, China
    The Second Affiliated Hospital Zhejiang University School OF Med
2021-07-20
Jul 20, 2021
S
Recruiting
  • Hematologic Malignancy
  • Prophylactic Donor lymphocytes infusions
  • Preventive Donor lymphocytes infusions
  • Saint Petersburg, Russian Federation
    RM Gorbacheva Research Institute
2021-08-16
Aug 16, 2021